DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Study Evaluating Piperacillin/Tazobactam in Complicated Urinary Infections.

Information source: Wyeth is now a wholly owned subsidiary of Pfizer
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Urinary Infections

Intervention: piperacillin/tazobactam (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Wyeth is now a wholly owned subsidiary of Pfizer

Official(s) and/or principal investigator(s):
Medical Monitor, Study Director, Affiliation: Wyeth is now a wholly owned subsidiary of Pfizer


The primary objective is to study the efficacy of piperacillin/tazobactam in patients with complicated urinary tract infections

Clinical Details

Official title: Study of the Safety and Efficacy of Piperacillin/Tazobactam in the Treatment of Patients With Complicated Urinary Infections.

Study design: Observational Model: Case-Only, Time Perspective: Prospective


Minimum age: 16 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- Hospitalized patients over 16 years of age with complicated urinary infection

produced by bacteria that are suspected to be susceptible to treatment with Piperacillin-tazobactam. Exclusion Criteria:

- Patients known, or thought to be hypersensitivity to beta-lactams

- Patients with an uncomplicated urinary tract infection

Locations and Contacts

Antequera (Málaga), Spain

Avila, Spain

Barcelona, Spain

Berga (Barcelona), Spain

Caceres, Spain

Castellón, Spain

Ciudad Real, Spain

Cuenca, Spain

Cádiz, Spain

Ferrol, Spain

Granada, Spain

Jaen, Spain

Las Palmas, Spain

Lorca (Murcia), Spain

Lugo, Spain

Lérida, Spain

Madrid, Spain

Osuna (Sevilla), Spain

Palma Mallorca, Spain

Pamplona, Spain

Pontevedra, Spain

Terrasa, Spain

Torrelavega, Spain

Valencia, Spain

Valladolid, Spain

Vitoria, Spain

Zaragoza, Spain

Additional Information

Starting date: June 2004
Last updated: September 24, 2009

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017